v2.4.0.8
STOCKHOLDERS' DEFICIENCY (Details Textual) (USD $)
 1 Months Ended 3 Months Ended 9 Months Ended 26 Months Ended
Jul. 31, 2013
Sep. 30, 2013
Sep. 30, 2013
Sep. 30, 2013
Dec. 31, 2012
Allocated Share-based Compensation Expense (in dollars)   $ 0 $ 2,242 $ 135,537  
Debt Instrument, Convertible, Conversion Price (in dollars per share)   $ 1.50 $ 1.50 $ 1.50  
Common Stock, Shares, Issued   16,344,728 16,344,728 16,344,728 16,225,000
Common Stock Dividends, Shares 9,728        
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value     $ 5,310    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term     5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period     1 year    
Director [Member]
          
Options Issued To Purchase Common Stock (in shares)     75,000    
Employee Stock Option [Member]
          
Options Issued To Purchase Common Stock (in shares)     1,287,500    
Series B Convertible Preferred Stock [Member]
          
Debt Instrument, Convertible, Conversion Price (in dollars per share)   $ 1.50 $ 1.50 $ 1.50  
Actual Conversion Price (in dollars per share)   $ 1.75 $ 1.75 $ 1.75  
Preferred Stock Convertible into Common Stock (in shares)   361,550 361,550 361,550  
Series Preferred Stock [Member]
          
Common Stock, Shares, Issued 109,728        
Series Preferred Stock [Member] | Employee Stock Option [Member]
          
Preferred Stock Convertible into Common Stock (in shares) 100,000